Sequential bevacizumab and oral cyclophosphamide for recurrent ovarian cancer.
Matulonis UA, Pereira L, Liu J, Lee H, Lee J, Whalen C, Campos S, Atkinson T, Hill M, Berlin S.
Matulonis UA, et al. Among authors: lee h, lee j.
Gynecol Oncol. 2012 Jul;126(1):41-6. doi: 10.1016/j.ygyno.2012.04.003. Epub 2012 Apr 6.
Gynecol Oncol. 2012.
PMID: 22487536
Clinical Trial.